Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection - Liu, Wei-Ren; Tian, Meng-Xin; Tang, Zheng; Fang, Yuan; Zhou, Yu-Fu; Song, Shu-Shu; Jiang, Xi-Fei; Wang, Han; Tao, Chen-Yang; Zhou, Pei-Yun; Qu, Wei-Feng; Ding, Zhen-Bin; et al. (British journal of cancer, 2020)
Keywords: 692/4028/67/1504/1610/4029; 692/53/2422; Biomedical and Life Sciences; Biomedicine; Cancer Research; Carcinoma, Hepatocellular - diagnosis; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - surgery; Decision making; Disease-Free Survival; Drug Resistance; Epidemiology; Female; Gene Expression Regulation, Neoplastic - genetics; Hepatocellular carcinoma; Humans; Immunohistochemistry; Immunohistochemistry - methods; Liver cancer; Liver Neoplasms - diagnosis; Liver Neoplasms - genetics; Liver Neoplasms - pathology; Liver Neoplasms - surgery; Male; Middle Aged; Molecular Medicine; Neoplasm Proteins - genetics; Neoplasm Recurrence, Local - diagnosis; Neoplasm Recurrence, Local - genetics; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - surgery; Nomograms; Oncology; Patients; Prognosis; Proportional Hazards Models; Survival; Survival Rate; Transcriptome - genetics